These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24916909)

  • 1. Can response-adaptive randomization increase participation in acute stroke trials?
    Tehranisa JS; Meurer WJ
    Stroke; 2014 Jul; 45(7):2131-3. PubMed ID: 24916909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review.
    Flory JH; Mushlin AI; Goodman ZI
    J Gen Intern Med; 2016 Dec; 31(12):1511-1518. PubMed ID: 27384536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferral of Consent in Acute Stroke Trials.
    Shamy MCF; Dewar B; Chevrier S; Wang CQ; Page S; Goyal M; Demchuk AM; Hill MD
    Stroke; 2019 Apr; 50(4):1017-1020. PubMed ID: 30869570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials.
    Nowacki AS; Zhao W; Palesch YY
    Stat Methods Med Res; 2017 Jun; 26(3):1078-1092. PubMed ID: 25586325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials.
    Cohen ER; O'Neill JM; Joffres M; Upshur RE; Mills E
    Dev World Bioeth; 2009 Aug; 9(2):74-80. PubMed ID: 18445072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How preliminary data affect people's stated willingness to enter a hypothetical randomized controlled trial.
    Ubel PA; Merz JF; Shea J; Asch DA
    J Investig Med; 1997 Dec; 45(9):561-6. PubMed ID: 9444883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of persons with mental retardation to consent to participate in randomized clinical trials.
    Fisher CB; Cea CD; Davidson PW; Fried AL
    Am J Psychiatry; 2006 Oct; 163(10):1813-20. PubMed ID: 17012694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience.
    Yeatts SD; Martin RH; Coffey CS; Lyden PD; Foster LD; Woolson RF; Broderick JP; Di Tullio MR; Jungreis CA; Palesch YY;
    Stroke; 2014 May; 45(5):1408-14. PubMed ID: 24699059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who says "no" to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program.
    O'Neill ZR; Deptuck HM; Quong L; Maclean G; Villaluna K; King-Azote P; Sharma M; Butcher K; Hart RG; Field TS
    Trials; 2019 May; 20(1):313. PubMed ID: 31151483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives for randomization in lifestyle intervention studies in cancer patients were not better than conventional randomization.
    Velthuis MJ; May AM; Monninkhof EM; van der Wall E; Peeters PH
    J Clin Epidemiol; 2012 Mar; 65(3):288-92. PubMed ID: 21856119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method to determine stroke trial success using multidimensional pooled control functions.
    Mandava P; Kent TA
    Stroke; 2009 May; 40(5):1803-10. PubMed ID: 19286598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
    Kim SY; Flory J; Relton C
    Clin Trials; 2018 Feb; 15(1):9-16. PubMed ID: 29224380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment difficulties in obstetric trials: a case study and review.
    Madan A; Tracy S; Reid R; Henry A
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):546-52. PubMed ID: 25350684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending acute trials to remote populations: a pilot study during interhospital helicopter transfer.
    Leira EC; Ahmed A; Lamb DL; Olalde HM; Callison RC; Torner JC; Adams HP;
    Stroke; 2009 Mar; 40(3):895-901. PubMed ID: 19131655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of waivers of consent on recruitment in acute stroke trials: A systematic review.
    Feldman WB; Kim AS; Josephson SA; Lowenstein DH; Chiong W
    Neurology; 2016 Apr; 86(16):1543-51. PubMed ID: 27009262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.